OncoSec Medical Incorporated Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation (Tables)

12 Months Ended

Jul. 31, 2015

	Option Shares Outstanding (1)		Weighted-Average Exercise Price (1)		Aggregate Intrinsic Value ($000’s)
Balance at July 31, 2012	158,750		$	4.80	$	24
Granted	150,750		4.40		232
Exercised	(38,325	)	3.60		52
Forfeited / Cancelled / Expired	(13,675	)	6.60		9

Balance at July 31, 2013	257,500		4.60		372
Granted	451,000		13.20		1
Exercised	(89,999	)	4.20		846
Forfeited / Cancelled / Expired	(30,456	)	5.20		65

Balance at July 31, 2014	588,045		11.20		844
Granted	608,501		7.45		1
Exercised	(308	)	5.60		1
Forfeited / Cancelled / Expired	(47,474	)	12.29		46

Balance at July 31, 2015	1,148,764		9.20		216

Exercisable at July 31, 2015	616,511		$	9.81	$	206

(1)

Recast to reflect the 1-for-20 reverse stock split effected May 2015

Range of Exercise Prices (1)			Number of Shares Outstanding		Weighted Average Contractual Life (in years)		Number Of Shares Exercisable			Weighted Average Remaining Contractual Life (in years)
$	3.60 -16.10		1,148,764		8.2		$	616,511		7.3

Common Stock options outstanding (within the 2011 Plan and outside of the terms of the 2011 Plan)		1,148,764
Common Stock warrants		1,895,102
Common Stock options authorized for future grant under the 2011 Plan		2,652,434
		5,696,300